More News

Filter
Date
9 Results
CATCH den Tumor – Verbesserung der Krebsimmuntherapie durch Hochdurchsatz-Messungen der T-Zell-Rezeptor-Avidität

In focus: What exactly does Dr. Lucie Loyal do?

In today’s “In Focus” feature, we introduce Dr. Lucie Loyal. She is a researcher at the Berlin Institute of Health (BIH), where she conducts research into cancer immunotherapies. She is currently receiving funding from EKFS as part of its First and Second Applications funding line.

Publication Prizes

Eight publication prizes for research excellence

EKFS honors outstanding work funded by the Foundation in 2025

Translational Research

Registration now open for the ForTra-BIH Workshop on Gene and Cell Therapy

Join the non-profit subsidiary ForTra gGmbH für Forschungstransfer der Else Kröner-Fresenius-Stiftung (ForTra), together with the SPARK-BIH team of the National Strategy for Gene and Cell Therapy, for an inspiring and forward-looking workshop dedicated to Gene and Cell Therapy (GCT).

Else Kröner Graduate Schools

Support for early-career researchers: new graduate schools approved

Graduate schools in Bonn, Leipzig, and Rostock to each receive €900,000 in funding

Image

Merry Christmas and a Happy New Year

from the EKFS team!

Else Kröner Exzellenzstipendien: Ausschreibung

EKFS supports cutting-edge medical research with nine Excellence Fellowships

Up to 350,000 euros awarded per research project

Image

In focus: What exactly does Prof. Dr. Constanze Schmidt do?

New Director of the Clinic for Cardiology and Pneumology at the University Medical Center Göttingen (UMG)

Image

EKFS participates in the “Rudern gegen Krebs” charity regatta for the first time

On the water for a good cause: Team Else shows commitment in Mainz

Image

20 Jahre Ernährungskompetenz

Das Else Kröner Fresenius Zentrum für Ernährungsmedizin feiert Jubiläum